Wei Wang

Dr. Wei Wang


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 March 2010 in Journal of Investigative Medicine
Verified
Journal Article
Closed access
PSPei-Cheng Shen
Pei-Cheng Shen
LHLiqun He
Liqun He
YTYing Tang
Ying Tang
QWQing Wang
Qing Wang
WWWei Wang
Wei Wang
JLJie Li
Jie Li
Aims: Many patients with immunoglobulin class A (IgA) nephropathy (IgAN) present with asymptomatic urinary abnormalities. The purpose of this study was to observe the clinicopathological characteristics and prognostic factors in asymptomatic IgAN. Methods: Eighty-six asymptomatic IgAN patients (49 males and 37 females) were investigated; 82 of them were followed up during a mean ± SD period of 66.7 ± 19.7 months. Results: At biopsy, 18 patients (21%) presented with pure hematuria (HU), 29 patients (34%) presented with proteinuria alone (PU), and 39 patients (45%) presented concomitant hematuria and proteinuria with severe pathological lesions. Meanwhile, 16% and 26% had renal insufficiency and hypertension, respectively. Finally, urinary abnormalities of 15% of the patients disappeared, 25% of HU developed proteinuria, 47% of concomitant hematuria and proteinuria, and 32% of PU appeared to have increase of proteinuria, and 14% of PU developed hematuria. Fifteen (24%) of the patients with normal blood pressure initially became hypertensive and 18 (22%) of the patients with normal renal function initially developed renal insufficiency. Twenty-four patients (29%) had doubling of serum creatinine level, and 13 patients (16%) progressed to end-stage renal disease. Prednisone therapy and antihypertensive treatment significantly improved proteinuria and renal function deterioration. Hematuria, hypertension during follow-up, and tubulointerstitial lesions were independent risk factors predictive of the ultimate development of renal progression. Conclusions: The renal outcome of asymptomatic IgAN is guarded. Hematuria, hypertension during follow-up, and tubulointerstitial lesions may be important markers to monitor renal progression in the course.

23 November 2023 in Clinical and Experimental Rheumatology
Verified
Journal Article
Closed access
XKXiufang Kong
Xiufang Kong
WWWei Wang
Wei Wang
Full Papers; Authors: X. Kong, W. Wang

13 June 2024 in Biological Research For Nursing
Verified
Journal Article
Closed access
XMXinting Min
Xinting Min
XKXiufang Kong
Xiufang Kong
WWWei Wang
Wei Wang
Background: Oxidative stress has been implicated in the pathogenesis of hearing loss (HL). Dietary intake is a modifiable factor that could influence the oxidant and antioxidant capacity. We hypothesized that a higher composite dietary antioxidant index (CDAI) is associated with a reduced odds for HL. Methods: Adult participants from the 2001–2012 & 2015–2018 National Health and Nutrition Examination Study were included in this cross-sectional study. The CDAI was calculated from vitamins A, C, E, selenium, zinc, and caretenoid through 24-h dietary recall. Outcomes were HL, speech frequency HL (SFHL), and high frequency HL (HFHL). The associations between CDAI and HL, SFHL, and HFHL were evaluated by weighted multivariable logistic regression. Results: CDAI was associated with lower odds of HL (OR = 0.98, 95%CI 0.95–1.00, p = .043) and SFHL (OR = 0.97, 95%CI 0.95–1.00, p = .041), but not HFHL (OR = 0.98, 95%CI 0.96–1.00, p = .118) after adjustment for confounders. The multivariable-adjusted model showed a significant trend toward decreased risk of HL, SFHL, and HFHL with increasing CDAI quartile (all p for trend < 0.05). Restricted cubic spline analysis suggested that the associations between CDAI and HL, SFHL, and HFHL were L-shaped, with inflection points of CDAI at −0.61, 2.33, and 4.32, respectively. Subgroup analysis showed that participants with exposure to loud noise benefited from a higher CDAI for SFHL ( p for interaction = 0.039). Conclusion: Higher CDAI is associated with reduced odds of HL and SFHL in the U.S. adult population and serves as a promising intervention target to be further explored in prospective longitudinal studies in the future.

19 January 2025 in Endocrine Practice
Verified
Journal Article
Closed access
XKXiufang Kong
Xiufang Kong
WWWei Wang
Wei Wang

17 August 2024 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
XKXiufang Kong
Xiufang Kong
WWWei Wang
Wei Wang
Background: Metabolic syndrome (MetS) is a common comorbidity in psoriasis. However, the associations between MetS, psoriasis and mortality remain largely unclear. Objectives: To investigate the synergistic effect of MetS and psoriasis on total and cardiovascular disease (CVD) mortality in a representative sample of US adults. Methods: In total, 14 930 participants from the 2003–2006 and 2009–2014 National Health and Nutrition Examination Survey were included in this prospective, nationwide cohort study. Participants were stratified into the psoriasis−/MetS− (reference) group, psoriasis−/MetS+ group, psoriasis+/MetS− group and psoriasis+/MetS+ group. Results: Overall, 14 930 participants, 50.71% were male, with a mean age of 43 years, were included in the final analysis. The weighted percentages of participants in the psoriasis−/MetS−, psoriasis−/MetS+, psoriasis+/MetS− and psoriasis+/MetS+ groups were 72.77%, 24.36%, 1.94% and 0.93%, respectively. In total, 874 deaths (246 of which were related to CVD) occurred during a median follow-up of 110 months. Compared with the reference group, the hazard ratios in the psoriasis−/MetS+, psoriasis+/MetS− and psoriasis+/MetS+ groups were 1.788 [95% confidence interval (CI) 1.486–2.152], 0.858 (95% CI 0.431–1.707) and 2.050 (95% CI 1.028–4.092), respectively, for all-cause mortality, and 1.856 (1.350–2.552), 1.229 (95% CI 0.292–5.181) and 4.571 (95% CI 1.724–12.119), respectively, for CVD mortality. Subgroup analysis showed that this association was not influenced by participants’ age, sex, physical activity, smoking, estimated glomerular filtration rate, or urinary albumin/creatinine ratio. Similar results were obtained in the sensitivity analysis of the main results. Conclusions: Presence of comorbid MetS significantly increases all-cause and CVD mortality in patients with psoriasis. Dermatologists can potentially aid in reducing mortality rates in patients with psoriasis through targeted screening for MetS.